BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15802307)

  • 1. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn SJ
    Int Immunol; 2005 May; 17(5):607-13. PubMed ID: 15802307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection.
    Antúnez MI; Cardoni RL
    Exp Parasitol; 2004; 106(3-4):85-94. PubMed ID: 15172215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
    Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
    Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.
    Duthie MS; Kahn SJ
    Immunology; 2006 Nov; 119(3):355-61. PubMed ID: 16879622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
    Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
    Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses.
    Miyazaki Y; Iwabuchi K; Iwata D; Miyazaki A; Kon Y; Niino M; Kikuchi S; Yanagawa Y; Kaer LV; Sasaki H; Onoé K
    Scand J Immunol; 2008 Mar; 67(3):230-7. PubMed ID: 18226013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
    Biburger M; Tiegs G
    J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
    Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
    Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
    Vitelli-Avelar DM; Sathler-Avelar R; Massara RL; Borges JD; Lage PS; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Clin Exp Immunol; 2006 Jul; 145(1):81-92. PubMed ID: 16792677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn M; White M; Kapur RP; Kahn SJ
    Infect Immun; 2005 Jan; 73(1):181-92. PubMed ID: 15618153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.
    Lieke T; Graefe SE; Klauenberg U; Fleischer B; Jacobs T
    Infect Immun; 2004 Dec; 72(12):6817-25. PubMed ID: 15557602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
    Kajiwara T; Tomita Y; Okano S; Iwai T; Yasunami Y; Yoshikai Y; Nomoto K; Yasui H; Tominaga R
    Transplantation; 2007 Jan; 83(2):184-92. PubMed ID: 17264815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK1.1 cells are required to control T cell hyperactivity during Trypanosoma cruzi infection.
    Cardillo F; Nomizo A; Postól E; Mengel J
    Med Sci Monit; 2004 Aug; 10(8):BR259-67. PubMed ID: 15277986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.